Sun, R., Yang, N., Kong, B., Cao, B., Feng, D., Yu, X., . . . Wang, G. (2017). Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway. Mol Pharmacol.
Styl ChicagoSun, Runbin, et al. "Orally Administered Berberine Modulates Hepatic Lipid Metabolism By Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway." Mol Pharmacol 2017.
Citace podle MLASun, Runbin, et al. "Orally Administered Berberine Modulates Hepatic Lipid Metabolism By Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway." Mol Pharmacol 2017.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..